Beijing Pre-diabetes Reversion Program.

Trial Profile

Beijing Pre-diabetes Reversion Program.

Phase of Trial: Phase IV

Latest Information Update: 30 Dec 2013

At a glance

  • Drugs Pioglitazone (Primary)
  • Indications Diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 May 2012 Actual end date changed from Jul 2007 to Jun 2010 as reported by
    • 24 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top